股本结构
单位：万股
| 公告日期 | 2025-04-29 | 2025-05-14 | 2024-11-05 | 2024-11-05 | 2024-08-06 | 2024-08-06 |
|---|---|---|---|---|---|---|
| 证券总股本 | 6456.18 | 6447.02 | 6424.02 | 6417.91 | 6709.88 | 6273.44 |
| 普通股本 | 6456.18 | 6447.02 | 6424.02 | 6417.91 | 6709.88 | 6273.44 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-04-28 | 2025-03-31 | 2024-10-29 | 2024-09-30 | 2024-08-06 | 2024-07-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-04-29 | 6456.18 | 未披露 | 定期报告 | 2025-04-28 |
| 2025-05-14 | 6447.02 | 未披露 |
更多>>
From December 31, 2024 to March 31, 2025
Shares issued in at-the-market offering
|
2025-03-31 |
| 2025-03-10 | 6424.02 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Exercise of stock options and RSU vesting
Shares issued in at-the-market offering
Shares purchased in Employee Stock Purchase Plan
|
2024-12-31 |
| 2024-11-05 | 6424.02 | 未披露 | 定期报告 | 2024-10-29 |
| 2024-11-05 | 6417.91 | 未披露 |
更多>>
From June 30, 2024 to September 30, 2024
Exercise of stock options and RSU vesting
Shares issued in at-the-market offering
|
2024-09-30 |
| 2024-08-06 | 6709.88 | 未披露 |
更多>>
On August 6, 2024 the Company issued and sold 4,364,440 shares of common stock
|
2024-08-06 |
| 2024-08-06 | 6273.44 | 未披露 | 定期报告 | 2024-07-30 |
| 2024-08-06 | 6207.20 | 未披露 |
更多>>
From March 31, 2024 to June 30, 2024
Exercise of stock options and RSU vesting
|
2024-06-30 |
| 2024-04-26 | 6185.55 | 未披露 | 定期报告 | 2024-04-22 |
| 2024-05-07 | 6181.65 | 未披露 |
更多>>
From December 31, 2023 to March 31, 2024
Exercise of stock options
Shares purchased in Employee Stock Purchase Plan
|
2024-03-31 |
| 2024-03-12 | 6177.20 | 未披露 | 定期报告 | 2024-03-07 |
| 2024-03-12 | 6176.88 | 未披露 |
更多>>
From December 31,2022 to December 31,2023
Exercise of pre-funded warrants
Shares issued in at-the-market offering
Exercise of stock options
Issuance of common stock, net of issuance costs
Shares purchased in Employee Stock Purchase Plan
|
2023-12-31 |
| 2023-11-07 | 6176.07 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Issuance of common stock, net of issuance costs
Shares issued in at-the-market offering
Exercise of stock options
Shares purchased in Employee Stock Purchase Plan
|
2023-09-30 |
| 2023-08-08 | 6172.97 | 未披露 | 定期报告 | 2023-08-03 |
| 2023-07-28 | 5887.91 | 未披露 |
更多>>
Common stock offered 12,500,000 shares by the company
|
2023-08-01 |
| 2023-08-08 | 4637.91 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Exercise of stock options
Shares issued in at-the-market offering
|
2023-06-30 |
| 2023-05-09 | 4403.53 | 未披露 | 定期报告 | 2023-05-03 |
| 2023-05-09 | 4376.55 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Exercise of pre-funded warrants
Shares purchased in Employee Stock Purchase Plan
|
2023-03-31 |
| 2023-03-22 | 4372.00 | 未披露 | 定期报告 | 2023-03-17 |
| 2022-11-10 | 4039.44 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Exercise of stock options
Exercise of pre-funded warrants
Shares purchased in Employee Stock Purchase Plan
|
2022-09-30 |
| 2022-08-15 | 4014.57 | 未披露 | 定期报告 | 2022-08-10 |
| 2022-08-15 | 4009.71 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Exercise of stock options
Issuance of common stock, net of issuance costs
|
2022-06-30 |
| 2022-04-27 | 4009.71 | 未披露 |
更多>>
1.Common stock offered by 16,276,987 shares of common stock.
2.The number of shares of common stock that will be outstanding immediately after this offering as shown above is based on 23,818,411 shares of common stock outstanding as of March 31, 2022.
|
2022-04-19 |
| 2022-04-27 | 2382.01 | 未披露 | 定期报告 | 2022-04-11 |
| 2022-05-10 | 2381.84 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Exercise of stock options
|
2022-03-31 |
| 2022-03-15 | 2367.26 | 未披露 | 定期报告 | 2022-03-10 |
| 2022-03-15 | 2366.87 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Exercise of stock options
|
2021-12-31 |
| 2021-11-09 | 2366.47 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Exercise of stock options
|
2021-09-30 |
| 2021-08-11 | 2366.16 | 未披露 | 定期报告 | 2021-08-06 |
| 2021-08-11 | 2357.06 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Exercise of stock options
|
2021-06-30 |
| 2021-05-12 | 2348.31 | 未披露 | 定期报告 | 2021-05-07 |
| 2021-05-12 | 2347.37 | 未披露 |
更多>>
From December 31, 2020 to March 31, 2021
Exercise of stock options
|
2021-03-31 |
| 2021-03-25 | 2346.41 | 未披露 | 定期报告 | 2021-03-19 |
| 2021-03-25 | 2338.50 | 未披露 |
更多>>
from December 31, 2019 to December 31, 2020
Conversion of convertible preferred stock into common stock
Issuance of shares to acquire in-process research and development
Issuance of Series A-2 Convertible Preferred Stock, net of issuance costs of $0.1 million
Initial public offering, net of issuance costs of $3.9 million
Exercise of stock options
|
2020-12-31 |
| 2020-11-12 | 2337.28 | 未披露 | 定期报告 | 2020-11-06 |
| 2020-11-12 | 2336.49 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Conversion of convertible preferred stock into common stock
Issuance of shares to acquire in-process research and development
Initial public offering, net of issuance costs of $3,900,000
Exercise of stock options
|
2020-09-30 |
| 2020-09-03 | 2336.49 | 未披露 | 定期报告 | 2020-08-31 |
| 2020-07-24 | 2231.49 | 未披露 |
更多>>
1.Common stock offered 7,000,000 shares
2.The number of shares of common stock to be outstanding after this offering is based on 1,361,001 shares of common stock outstanding as of July 17, 2020
|
2020-07-24 |
From December 31, 2024 to March 31, 2025
Shares issued in at-the-market offering
From December 31, 2023 to December 31, 2024
Exercise of stock options and RSU vesting
Shares issued in at-the-market offering
Shares purchased in Employee Stock Purchase Plan
From June 30, 2024 to September 30, 2024
Exercise of stock options and RSU vesting
Shares issued in at-the-market offering
On August 6, 2024 the Company issued and sold 4,364,440 shares of common stock
From March 31, 2024 to June 30, 2024
Exercise of stock options and RSU vesting
From December 31, 2023 to March 31, 2024
Exercise of stock options
Shares purchased in Employee Stock Purchase Plan
From December 31,2022 to December 31,2023
Exercise of pre-funded warrants
Shares issued in at-the-market offering
Exercise of stock options
Issuance of common stock, net of issuance costs
Shares purchased in Employee Stock Purchase Plan
From June 30, 2023 to September 30, 2023
Issuance of common stock, net of issuance costs
Shares issued in at-the-market offering
Exercise of stock options
Shares purchased in Employee Stock Purchase Plan
Common stock offered 12,500,000 shares by the company
From March 31, 2023 to June 30, 2023
Exercise of stock options
Shares issued in at-the-market offering
From December 31, 2022 to March 31, 2023
Exercise of pre-funded warrants
Shares purchased in Employee Stock Purchase Plan
From June 30, 2022 to September 30, 2022
Exercise of stock options
Exercise of pre-funded warrants
Shares purchased in Employee Stock Purchase Plan
From March 31, 2022 to June 30, 2022
Exercise of stock options
Issuance of common stock, net of issuance costs
1.Common stock offered by 16,276,987 shares of common stock.
2.The number of shares of common stock that will be outstanding immediately after this offering as shown above is based on 23,818,411 shares of common stock outstanding as of March 31, 2022.
From December 31, 2021 to March 31, 2022
Exercise of stock options
From December 31, 2020 to December 31, 2021
Exercise of stock options
From June 30, 2021 to September 30, 2021
Exercise of stock options
From March 31, 2021 to June 30, 2021
Exercise of stock options
From December 31, 2020 to March 31, 2021
Exercise of stock options
from December 31, 2019 to December 31, 2020
Conversion of convertible preferred stock into common stock
Issuance of shares to acquire in-process research and development
Issuance of Series A-2 Convertible Preferred Stock, net of issuance costs of $0.1 million
Initial public offering, net of issuance costs of $3.9 million
Exercise of stock options
From June 30, 2020 to September 30, 2020
Conversion of convertible preferred stock into common stock
Issuance of shares to acquire in-process research and development
Initial public offering, net of issuance costs of $3,900,000
Exercise of stock options
1.Common stock offered 7,000,000 shares
2.The number of shares of common stock to be outstanding after this offering is based on 1,361,001 shares of common stock outstanding as of July 17, 2020